RT Book, Section
A1 Fitzpatrick, Meghan E.
A1 Prendergast, Niall T.
A1 Rivera-Lebron, Belinda
A2 Papadakis, Maxine A.
A2 McPhee, Stephen J.
A2 Rabow, Michael W.
A2 McQuaid, Kenneth R.
SR Print(0)
ID 1193145914
T1 Allergic Bronchopulmonary Aspergillosis (Mycosis)
T2 Current Medical Diagnosis & Treatment 2023
YR 2023
FD 2023
PB McGraw-Hill Education
PP New York, NY
SN 9781264687343
LK accessmedicine.mhmedical.com/content.aspx?aid=1193145914
RD 2024/09/11
AB Key  Clinical  Updates  in  Allergic  Bronchopulmonary  Aspergillosis  (Mycosis)For  patients  with  frequent  exacerbations,  the  use  of  biologic  agents,  such  as  anti-IgE  (omalizumab),  anti-IL-5  (mepolizumab,  benralizumab),  or  anti-IL4  receptor  (dupilumab),  has  been  shown  to  improve  outcomes.Koutsokera  A  et  al.  J  Cyst  Fibros.  [PMID:  31405730]